… abnormalities including cytokine storm, hypercoagulable state … drugs targeting cytokine storm
in patients with SARS-CoV-2. … in cytokine release syndrome are now being tested in clinical …

… consideration. In this review, we summarize the latest data available about the role of the
cytokine storm in … moment, several ongoing large-scale clinical trials will surely shed more light …

… -2 infection, generation of cytokine storm, the interdependence between inflammation and
… Scholar for relevant reports using COVID-19, cytokine storm, and coagulation as keywords. …

… overlapping clinical entities that make up the cytokine storm … Sepsis is the largest category
of cytokine storm syndromes … consideration in the management of patients with cytokine …

… The “cytokine storm” (CS) in COVID-19 leads to the worst … cytokine antagonists may be
the key to reducing mortality. After reviewing published studies, we proposed a Cytokine Storm …

… release of polypeptide mediators, or cytokines, that generate … in disease pathogenesis these
same cytokines are also the … We argue that understanding cytokine storms in their various …

… Clinical investigations in patients with COVID-19 has shown a … cytokine storm - an uncontrolled
systemic inflammatory response resulting from the release of pro-inflammatory cytokines …

… These considerations suggest that, beyond antiviral therapy and supportive care, it will be …
from the available evidence and from current clinical experience in cytokine storm syndromes. …

… Given the hypothesis that MSC therapy might prevent the triggering of cytokine storm and
promote endogenous repair, several clinical trials are Looking at the safety and therapeutic …

… also good indicators of cytokine storm pathology at the bedside. Also, there is a significant
decrease in lymphocytes in COVID-19, and sufficient consideration is needed for secondary …